Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

(2019) Boris Julg et al.   Lancet HIV

Current challenges and recent advances in the search for a cure for HIV

(2019) R Brad Jones   Journal of the International AIDS Society

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals

(2019) Rémi Fromentin et al.   Nature Communications

Durable Control of HIV Infection in the Absence of Antiretroviral Therapy

(2019) Tae-Wook Chun et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium

(2019) Nir Eyal et al.   JOURNAL OF INFECTIOUS DISEASES

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

(2019) Thomas S. Uldrick et al.   JAMA Oncology

CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia

(2019) Lei Xu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Posttraumatic Stress Disorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals

(2018) Perrine Roux et al.   JOURNAL OF CLINICAL PSYCHIATRY

Research altruism as motivation for participation in community-centered environmental health research

(2018) Jennifer S. Carrera et al.   SOCIAL SCIENCE & MEDICINE

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

(2018) Yotam Bar-On et al.   NATURE MEDICINE

Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial

(2018) Romain Palich et al.   AIDS

Will CURE trials introduce an uncomfortable revolution in the field of HIV research?

(2017) Christel Protière et al.   HIV CLINICAL TRIALS

Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France

(2017) Sylvie Brégigeon-Ronot et al.   Patient Preference and Adherence

Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC)

(2017) Christel Protière et al.   PLoS One

Larger is not necessarily better! Impact of HIV care unit characteristics on virological success: results from the French national representative ANRS-VESPA2 study

(2016) Luis Sagaon-Teyssier et al.   HEALTH POLICY

A global survey of HIV-positive people's attitudes towards cure research

(2016) R Simmons et al.   HIV MEDICINE

Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio

(2016) Rahul Kumar   JOURNAL OF MEDICAL ETHICS

Why high-risk, non-expected-utility-maximising gambles can be rational and beneficial: the case of HIV cure studies

(2016) Lara Buchak   JOURNAL OF MEDICAL ETHICS

Why cure, why now?

(2016) Daniel R Kuritzkes   JOURNAL OF MEDICAL ETHICS

Towards Multidisciplinary HIV-Cure Research: Integrating Social Science with Biomedical Research

(2016) Cynthia I. Grossman et al.   TRENDS IN MICROBIOLOGY

Barriers to a cure for HIV in women

(2016) Sara Gianella et al.   Journal of the International AIDS Society

Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey

(2016) Marie Suzan-Monti et al.   Journal of the International AIDS Society

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents

(2016) Héloïse M. Delagrèverie et al.   Open Forum Infectious Diseases

Exploring the Social Meaning of Curing HIV: A Qualitative Study of People Who Inject Drugs in Guangzhou, China

(2015) Carissa E. Chu et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

A Longitudinal Study of Post-Traumatic Growth and Psychological Distress in Colorectal Cancer Survivors

(2015) Stefano Occhipinti et al.   PLoS One

Social and ethical implications of HIV cure research

(2014) Joseph D. Tucker et al.   AIDS

Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice

(2014) Ariel Halper-Stromberg et al.   CELL

The Effect of Including an Opt-Out Option in Discrete Choice Experiments

(2014) Jorien Veldwijk et al.   PLoS One

Simulation-Based Confidence Intervals for Functions With Complicated Derivatives

(2013) Micha Mandel   AMERICAN STATISTICIAN

Past, present and future: 30 years of HIV research

(2013) Françoise Barré-Sinoussi et al.   NATURE REVIEWS MICROBIOLOGY

Predictors of posttraumatic growth in women with breast cancer

(2013) Suzanne C. Danhauer et al.   PSYCHO-ONCOLOGY

Controversies in HIV cure research

(2012) Rowena Johnston et al.   Journal of the International AIDS Society

Taking Conjoint Analysis to Task

(2011) Mandy Ryan   VALUE IN HEALTH

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

(2011) John F.P. Bridges et al.   VALUE IN HEALTH

Finding a cure for HIV: will it ever be achievable?

(2011) Sharon R Lewin et al.   Journal of the International AIDS Society

Labeled versus Unlabeled Discrete Choice Experiments in Health Economics: An Application to Colorectal Cancer Screening

(2009) Esther W. de Bekker-Grob et al.   VALUE IN HEALTH